Santosh Vetticaden MD, PhD, MBA

Santosh Vetticaden, MD, PhD has been Senior Vice President and Chief Medical Officer at Mast Therapeutics, Inc., a publicly traded biopharmaceutical company based in San Diego, CA, since September 2012. He has held several senior level positions leading drug development across Phase I through Phase IV at biotech and large pharmaceutical companies and has experience spanning multiple therapeutic areas ranging from antithrombotics to antiinfectives.

He has previously served as the Chief Medical Officer at other public companies notably, Cubist Pharmaceuticals, Inc., and Maxygen, Inc. Prior to Maxygen, Dr. Vetticaden held senior management positions at Scios, Inc., a subsidiary of Johnson & Johnson, including vice president, clinical research. Previously, he held senior roles related to drug development at Aventis Pharmaceuticals (now Sanofi) and the Whitehall-Robins Healthcare division of American Home Products Corporation (now Pfizer). Dr. Vetticaden earned his MD from the University of Maryland and a PhD in pharmacokinetics and pharmacodynamics from Virginia Commonwealth University. He completed his residency in internal medicine at the Baylor College of Medicine.